SEARL Pharmaceuticals: Major
Health Technology
Mkt Cap
52.2B
P/E (TTM)
44.17
EPS
-2.36
ROE
6.59%
Div Yield
—
About
The Searle Co. Ltd. is a holding company, which engages in the business of manufacturing pharmaceutical and other consumer products. The firm focuses on expanding its specialty generic branded portfolios and targeting differentiated products in the segments of cardiovascular, cold and cough, diabetes, infant formula, probiotics, and antibiotics. The company was founded on October 5, 1965 and is headquartered in Karachi, Pakistan.
Financial Highlights
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | ||
|---|---|---|---|---|---|---|
| Revenue | 28.60B | 29.40B | 25.80B | 29.91B | 26.22B | |
| Gross Profit | 13.91B | 13.41B | 11.22B | 12.77B | 11.91B | |
| Net Income | -1.39B | -2.40B | 348.57M | 2.35B | 3.68B | |
| EPS | -2.36 | -4.35 | 0.72 | 5.03 | 8.11 | |
| ROE | 2.44% | 3.18% | -0.34% | 8.67% | 17.92% | |
| ROA | 1.38% | 1.56% | -0.17% | 4.43% | 9.81% | |
| Gross Margin | 48.64% | 45.60% | 43.50% | 42.69% | 45.44% | |
| Net Margin | 2.76% | 3.37% | -0.39% | 7.86% | 14.03% | |
| Current Ratio | 1.63 | 1.13 | 1.36 | 1.71 | 1.65 | |
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 1.03 | |
| Free Cash Flow | -2.09B | 3.95B | -749.67M | -1.22B | 1.02B |